Posted in | News | Energy | Mining

Mawson Stakes Swedish Uranium Rare Earth Project

Mawson Resources Limited has announced the staking of a 100% interest in the 5047.5 hectare Tasjo uranium - rare earth element ("REE") - phosphate ("P2O5") project. Tasjo is located in the Jamtland and Vasterbotten counties, 200 kilometres north of the town of Ostersund in Northern Sweden.

The area was discovered in 1957 by the Swedish Atomic Energy Company using a vehicle-borne scintillometer. Subsequently, the area was explored in the early 1970's by the Swedish Geological Survey and the Stora Kopparberg and Boliden companies. A total of approximately 100 exploration drillholes have been drilled in the Tasjo field over a 200 square kilometre area.

The mineralized horizon is a 3 to 10 metre thick phosphatic calcareous sandstone of Lower Ordovician age (the "host sandstone"). Uranium mineralization is associated with the phosphate bearing mineral apatite, which constitutes 9 to 20% of the rock and calculations indicate that the uranium grade of the apatite is 0.16%.

Based on the report, "Geological Investigations in the Tasjo area in 1963 and 1964" by G. Armands of the Swedish Atomic Energy Company it is estimated that 75 to 150 million tonnes exist within the Tasjo field at a grade between 0.03% to 0.07% U3O8, 0.11% to 0.24% REE and 3.75% to 7.5% P2O5. Total contained metal within the field is estimated between 104 to 116 million pounds of U3O8, 165,000 to 180,000 tonnes of REE and 5.63 million tonnes of P2O5. The host sandstone unit occurs in two northeast orientated subcropping trends, each approximately 15 kilometres in length. Mawson has claimed approximately 80% of the subcropping host sandstone in the Tasjo field. The exploration target estimates above are based on the aforementioned report. The potential quantity and grade indicated is conceptual in nature, there has been insufficient exploration to define the target at this time and it is uncertain that further exploration will result in the definition of a resource. Additional information and maps of the Tasjo field can be found at http://www.mawsonresources.com/index.php?page(equal sign)ProjectsTasjo.

The Tasjo field is geologically analogous to the Florida Phosphorite Uranium Province, which contains the largest uranium resources in North America. In Florida, uranium occurs in carbonate-fluor-apatite at a grade of 0.007-0.0125% U3O8 (average 0.009%) and has been recovered as a by-product in the manufacture of phosphoric acid fertilizer. In 1988, two phosphoric acid manufacturing plants recovered approximately two million pounds of U3O8 (21% of U.S. production for 1988) from the phosphate rock mined in Florida.

Mr Hudson states, "The near-surface exploration target at Tasjo is vast. This project underpins Mawson's developing uranium portfolio and holds the potential to host a world-class uranium deposit, with significant rare earths credits." The company has applied for 12 exploration permits for a total area of 5047.5 hectares. To date seven permits areas have been granted: Kronotorpet nr 1 (199.99 hectares), Bodkullarna nr 1 (154.05 hectares) and Tasjo nr 1 to 5 (2956.9 hectares). Five permits, Tasjo nr 6 to 10 (1736.1 hectares), remain under application and are expected to be granted soon.

Ten nuclear power reactors provide approximately 50% of Sweden's electricity. Swedish mining legislation allows exploration for uranium and places no special restriction on mining where the uranium grade is less than 200 ppm or the production is less than 5 kg. When higher uranium grades are present, permitting will follow a process concerning "nuclear technical activity". Such permitting must pass before the Swedish government for decision making.

http://www.mawsonresources.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.